The new 5,000 sqm facility will house our expanded mRNA and protein engineering research teams.
BioGenesis enters multi-year agreement for siRNA therapeutic development collaboration.
Our research team's work on next-generation cap analogs for enhanced mRNA translation efficiency has been published.
Our glycoengineering team publishes new methodology for consistent Fc glycan modulation.